Assessment of the efficacy of an attenuated live marker classical swine fever vaccine (Flc-LOM-BE
Animals
Antibodies, Viral
/ blood
Classical Swine Fever
/ prevention & control
Classical Swine Fever Virus
/ immunology
Female
Infectious Disease Transmission, Vertical
/ prevention & control
Pregnancy
Pregnancy Complications, Infectious
/ prevention & control
Swine
Treatment Outcome
Vaccines, Attenuated
/ administration & dosage
Vaccines, Marker
/ administration & dosage
Vaccines, Synthetic
/ administration & dosage
Viral Vaccines
/ administration & dosage
Classical swine fever virus
E(rns) ELSIA
Flc-LOM-BE(rns)
Pregnant sow
Transplacental transmission
Journal
Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899
Informations de publication
Date de publication:
12 06 2019
12 06 2019
Historique:
received:
06
12
2018
revised:
20
04
2019
accepted:
24
04
2019
pubmed:
4
6
2019
medline:
24
7
2020
entrez:
2
6
2019
Statut:
ppublish
Résumé
Here, we constructed an attenuated live marker classical swine fever (CSF) vaccine (Flc-LOM-BE
Identifiants
pubmed: 31151802
pii: S0264-410X(19)30564-X
doi: 10.1016/j.vaccine.2019.04.076
pii:
doi:
Substances chimiques
Antibodies, Viral
0
Vaccines, Attenuated
0
Vaccines, Marker
0
Vaccines, Synthetic
0
Viral Vaccines
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3598-3604Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.